Abstract
Pharmacotherapy of Anxiety Disorders: Current Treatment
Afreen Ayesha
Anxiety disorders are the most common mental problems and a main source of handicap. While there keeps on being sweeping examination in posttraumatic stress problem (PTSD), misery and schizophrenia, there is a general shortage of novel meds being scrutinized for tension issues. This current audit's first point is to sum up flow pharmacological medicines (both endorsed and off-mark) for alarm issue (PD), summed up nervousness problem (GAD), social tension issue (SAD), and explicit fears (SP), including specific serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs), azapirones (e.g., buspirone), blended antidepressants (e.g., mirtazapine), antipsychotics, antihistamines (e.g., hydroxyzine), alpha and beta-adrenergic meds (e.g., propranolol, clonidine), and GABAergic prescriptions (benzodiazepines, pregabalin, and gabapentin).
Manuscript Submission
Submit your manuscript at Online Submission System
Google scholar citation report
Citations : 1101
International Journal of Pharmacy received 1101 citations as per google scholar report
International Journal of Pharmacy peer review process verified at publons
Indexed In
- CAS Source Index (CASSI)
- HINARI
- Index Copernicus
- Google Scholar
- The Global Impact Factor (GIF)
- Polish Scholarly Bibliography (PBN)
- Cosmos IF
- Open Academic Journals Index (OAJI)
- Directory of Research Journal Indexing (DRJI)
- EBSCO A-Z
- OCLC- WorldCat
- MIAR
- International committee of medical journals editors (ICMJE)
- Scientific Indexing Services (SIS)
- Scientific Journal Impact Factor (SJIF)
- Euro Pub
- Eurasian Scientific Journal Index
- Root indexing
- International Institute of Organized Research
- InfoBase Index
- International Innovative Journal Impact Factor
- J-Gate